Á lódáil...
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
The biology of atypical hemolytic uremic syndrome has been shown to involve inability to limit activation of the alternative complement pathway, with subsequent damage to systemic endothelial beds and the vasculature, resulting in the prototypic findings of a thrombotic microangiopathy. Central to t...
Na minha lista:
| Foilsithe in: | J Blood Med |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Dove Medical Press
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4835139/ https://ncbi.nlm.nih.gov/pubmed/27110144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S36249 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|